Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

5.36

+0.02 (0.37%)

At close: Apr 28, 2026, 4:00 PM EDT

5.37

+0.01 (0.19%)

After-hours: Apr 28, 2026, 4:47 PM EDT

Abeona Therapeutics Market Cap

Abeona Therapeutics has a market cap or net worth of $304.89 million as of April 28, 2026. Its market cap has increased by 50.27% in one year.

Market Cap

304.89M

Enterprise Value

138.45M

1-Year Change

50.27%

Ranking

#3549

Market Cap Chart

Since March 30, 2000, Abeona Therapeutics's market cap has increased from $78.00M to $304.89M, an increase of 290.89%. That is a compound annual growth rate of 5.36%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	304.60M	6.65%
Dec 31, 2025	285.60M	17.97%
Dec 31, 2024	242.10M	95.08%
Dec 29, 2023	124.10M	134.59%
Dec 30, 2022	52.90M	54.23%
Dec 31, 2021	34.30M	-77.83%
Dec 31, 2020	154.70M	-7.53%
Dec 31, 2019	167.30M	-51.12%
Dec 31, 2018	342.30M	-53.83%
Dec 29, 2017	741.40M	282.56%
Dec 30, 2016	193.80M	76.18%
Dec 31, 2015	110.00M	5,689.47%
Dec 31, 2014	1.90M	-70.31%
Dec 31, 2013	6.40M	10.34%
Dec 31, 2012	5.80M	-82.63%
Dec 30, 2011	33.40M	-15.87%
Dec 31, 2010	39.70M	-7.89%
Dec 31, 2009	43.10M	563.08%
Dec 31, 2008	6.50M	-43.97%
Dec 31, 2007	11.60M	17.17%
Dec 29, 2006	9.90M	7.61%
Dec 30, 2005	9.20M	-83.24%
Dec 31, 2004	54.90M	-21.57%
Dec 31, 2003	70.00M	255.33%
Dec 31, 2002	19.70M	-65.50%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Inhibikase Therapeutics	320.45M
Rezolute	318.89M
Cabaletta Bio	318.38M
Greenwich LifeSciences	315.88M
NervGen Pharma	314.01M
Anavex Life Sciences	312.30M
Foghorn Therapeutics	303.48M
AC Immune	300.58M

Market Cap Rankings